15 Fibromyalgia Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Fibromyalgia Studies in Bethesda

NCT00001373Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseas...

Bethesda, MD5,000 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT00001532Recruiting

Role of Genetic Factors in the Development of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung cells of patients wi...

Bethesda, MD3,500 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT01617408Recruiting

Brain Stimulation and Vision Testing

Background: -The brain has two systems for recognizing objects. One system recognizes what an object is, and the other system recognizes where the object is located. However, there is much about how ...

Bethesda, MD665 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT03231644Recruiting

Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry

The FD/MAS Patient Registry is an IRB-approved research study that that invites the patients and families to help answer some of the biggest questions about FD/MAS by completing questionnaires about t...

Bethesda, MD600 participantsTovah Burstein

View Study Details

NCT01434368Recruiting

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

Despite the clear importance of adolescence in the emergence of a number of disease states and processes, there is surprisingly little known about how the endocrine and metabolic events accompanying p...

Bethesda, MD480 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT02544022Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Background: People with neurofibromatosis 1 (NF1) who have plexiform neurofibromas (pNFs) can have pain that affects their daily lives. This study aims to improve questionnaires that measure their pa...

Bethesda, MD476 participantsNational Cancer Institute (NCI)

View Study Details

NCT02417740Recruiting

Natural History of Noncirrhotic Portal Hypertension

Background: \- Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood vessels of the liver. It seems to start slowly and not have many warning signs. ...

Bethesda, MD400 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT00598351Recruiting

Natural History Study of Patients With Neurofibromatosis Type 2

Objective With this prospective natural experiment trial on neurofibromatosis type 2 (NF2) study, we hope to understand the factors leading to tumor progression and neurological disease burden in NF2...

Bethesda, MD269 participantsNational Institute of Neurological Disorders and Stroke (NINDS)

View Study Details

NCT06222203Recruiting

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Background: Neurofibromatosis type 1 (NF1) is a genetic disease that can cause many symptoms. About half of people with NF1 will develop benign (noncancerous) tumors along nerves in the skin, brain, ...

Bethesda, MD225 participantsNational Cancer Institute (NCI)

View Study Details

NCT06188741Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Plexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was bas...

Bethesda, MDPHASE2200 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06880991Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Background: Neurofibromatosis 1 (NF1) is a disease that causes tumors to grow along the nerves. These include plexiform neurofibromas (pNF) and cutaneous neurofibromas (cNF). Both pNF and cNF can be ...

Bethesda, MD110 participantsNational Cancer Institute (NCI)

View Study Details

NCT05361811Recruiting

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Background: RASopathies are a group of genetic diseases that affect a child s development. They cause physical, cognitive, and behavioral symptoms. Caring for a child with a RASopathy can be stressfu...

Bethesda, MDNA70 participantsNational Cancer Institute (NCI)

View Study Details

NCT06507748Recruiting

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Background: Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors to grow along the nerves in the skin, brain, and other parts of the body. People with NF1 often have pain and may ...

Bethesda, MDNA70 participantsNational Cancer Institute (NCI)

View Study Details

NCT04750928Recruiting

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

Background: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical problems. The only treatment is surgery. Resear...

Bethesda, MDPHASE155 participantsNational Cancer Institute (NCI)

View Study Details

NCT02390752Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Background: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a drug called TURALIO(R) can shrink tumors ...

Bethesda, MDPHASE154 participantsNational Cancer Institute (NCI)

View Study Details

About Fibromyalgia Clinical Trials in Bethesda

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 15 fibromyalgia clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 12,174 participants. Research is being sponsored by National Human Genome Research Institute (NHGRI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Mental Health (NIMH) and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Bethesda — FAQ

Are there fibromyalgia clinical trials in Bethesda?

Yes, there are 15 fibromyalgia clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 15 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated July 17, 2026 from ClinicalTrials.gov